GUTS (Fractyl Health) Total Stockholders Equity: $-1.67 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GUTS Fractyl Health Inc GUTS
10 GF Score
Price $0.69
! 2 Warning Signs
View Full Analysis

What is Fractyl Health Total Stockholders Equity?

Fractyl Health GUTS -2.91% 10 Total Stockholders Equity is $-1.67 Mil as of Jun. 2026. GuruFocus rates GUTS with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

Fractyl Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $-1.67 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Fractyl Health's Book Value per Share for the quarter that ended in Jun. 2026 was $-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Fractyl Health's Debt-to-Equity for the quarter that ended in Jun. 2026 was -36.48.


Fractyl Health  (NAS:GUTS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Fractyl Health's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Fractyl Health's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fractyl Health Total Stockholders Equity Related Terms


Fractyl Health Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Fractyl Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fractyl Health Total Stockholders Equity Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial -209.33 -252.32 -325.06 28.42 9.46

Fractyl Health Quarterly Data
Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.21 -3.18 9.46 21.38 -1.67
GUTS
10GF Score
Fractyl Health Inc GUTS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $-1.67 Mil mean?
Fractyl Health (GUTS) has a Total Stockholders Equity of $-1.67 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Fractyl Health and its competitors.
Is Fractyl Health's Total Stockholders Equity too high?
Fractyl Health's current Total Stockholders Equity is $-1.67 Mil. Overall, Fractyl Health has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Fractyl Health's Total Stockholders Equity compare to PYPD and PLYX?
Fractyl Health's Total Stockholders Equity of $-1.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Fractyl Health and its competitors. Fractyl Health's current Total Stockholders Equity is $-1.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fractyl Health stock overvalued right now?
Fractyl Health (GUTS) has a current Total Stockholders Equity of $-1.67 Mil. The current Total Stockholders Equity is $-1.67 Mil. Fractyl Health's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Fractyl Health (GUTS), the current Total Stockholders Equity is $-1.67 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fractyl Health Business Description

Address 3 Van de Graaff Drive, Suite 200, Burlington, MA, USA, 01803
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
10GF Score

Get the complete analysis for GUTS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.69
Price